Long-term follow-up of extremely low birth weight infants with neonatal renal failure

Carolyn L Abitbol1, Charles R Bauer, Brenda Montané

  • 1Division of Pediatric Nephrology, University of Miami/Holtz Children's Hospital, PO Box 016960, Miami, FL 33101, USA. cabitbol@med.miami.edu

Insights

Preterm infants with extremely low birth weight and acute kidney injury face long-term risks. Early indicators like high proteinuria and creatinine predict worsening kidney function, enabling timely interventions.

Area of Science:

  • Pediatric Nephrology
  • Neonatal Intensive Care
  • Long-term Health Outcomes

Background:

  • Extremely low birth weight (ELBW) infants are vulnerable to neonatal acute kidney injury (AKI).
  • Long-term renal outcomes for ELBW survivors with neonatal AKI are not well-defined.
  • Understanding progression factors is crucial for this growing population.

Purpose of the Study:

  • To investigate the long-term renal function in preterm infants with ELBW and neonatal AKI.
  • To identify predictors of progressive renal disease in this cohort.
  • To inform surveillance and potential interventions for renal preservation.

Main Methods:

  • Retrospective study of 20 preterm infants with ELBW and neonatal AKI over 18 years.
  • Comparison of renal function trajectories (progressive disease vs. normal function).
  • Analysis of proteinuria (urine protein/creatinine ratio), serum creatinine, and body mass index as potential predictors.

Main Results:

  • Nine patients (45%) showed deterioration in renal function (low GFR group).
  • Increasing proteinuria strongly correlated with renal function decline (r=0.8, P<0.0001).
  • Key predictors for progression included proteinuria >0.6 at 1 year (100% sensitivity), serum creatinine >0.6 mg/dl at 1 year (80% PPV), and obesity (BMI >85th percentile).

Conclusions:

  • Early-onset proteinuria and elevated creatinine in ELBW infants with neonatal AKI predict long-term renal decline.
  • Identifying these risk factors allows for targeted monitoring and interventions.
  • Proactive management can help preserve renal function in survivors.

Related Concept Videos

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...